IC
TXG icon

IEQ Capital’s 10x Genomics TXG Stock Holding History

IEQ Capital’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2M Sell
526,390
-174,294
-25% -$4.57M 0.09% 193
2026
Q1 		$14.9M Sell
700,684
-59,412
-8% -$1.19M 0.07% 273
2025
Q4 		$12.4M Sell
760,096
-55,465
-7% -$838K 0.04% 299
2025
Q3 		$9.53M Buy
815,561
+278,199
+52% +$3.63M 0.03% 342
2025
Q2 		$6.22M Buy
537,362
+252,064
+88% +$2.3M 0.04% 365
2025
Q1 		$2.49M Buy
285,298
+127,186
+80% +$1.6M 0.02% 527
2024
Q4 		$2.27M Buy
158,112
+50,722
+47% +$800K 0.02% 468
2024
Q3 		$2.42M Buy
107,390
+3,432
+3% +$71K 0.03% 335
2024
Q2 		$2.02M Sell
103,958
-27,283
-21% -$714K 0.03% 339
2024
Q1 		$4.93M Buy
131,241
+3,117
+2% +$137K 0.07% 182
2023
Q4 		$7.17M Buy
128,124
+165
+0.1% +$7.18K 0.12% 120
2023
Q3 		$5.28M Sell
127,959
-892
-0.7% -$46.4K 0.11% 128
2023
Q2 		$7.2M Buy
128,851
+304
+0.2% +$16.5K 0.15% 107
2023
Q1 		$7.17M Buy
128,547
+2
+0% +$93 0.17% 97
2022
Q4 		$4.68M Buy
128,545
+23,813
+23% +$779K 0.13% 135
2022
Q3 		$2.98M Buy
104,732
+34,575
+49% +$1.32M 0.08% 171
2022
Q2 		$3.17M Buy
70,157
+1,499
+2% +$77.8K 0.1% 143
2022
Q1 		$5.22M Buy
68,658
+22,036
+47% +$1.93M 0.12% 106
2021
Q4 		$6.95M Buy
46,622
+10,930
+31% +$1.67M 0.16% 81
2021
Q3 		$5.2M Buy
35,692
+725
+2% +$124K 0.14% 96
2021
Q2 		$6.85M Buy
34,967
+30,620
+704% +$5.54M 0.2% 71
2021
Q1 		$787K Buy
+4,347
New +$751K 0.03% 233
2020
Q4 		– Sell
-2,304
Closed -$287K – 378
2020
Q3 		$287K Buy
+2,304
New +$242K 0.02% 309

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IEQ Capital's TXG Position: Q2 2026 in Review

IEQ Capital reduced its 10x Genomics (TXG) stake by 25% in Q2 2026, selling an estimated $4.57M and leaving 526,390 shares worth $20.2M. The position accounts for 0.09% of the portfolio, ranked #193.

IEQ Capital first reported a position in TXG in Q3 2020 and has held it in 23 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • IEQ Capital held 526,390 shares of 10x Genomics worth $20.2M as of Q2 2026.
  • IEQ Capital sold 174,294 10x Genomics shares in Q2 2026, an estimated $4.57M.
  • 10x Genomics made up 0.09% of IEQ Capital's portfolio in Q2 2026, its #193 holding.
  • IEQ Capital first reported a position in 10x Genomics in Q3 2020 and has held it in 23 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.